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Guinea worm infection in northern Nigeria: reflections on a
disease approaching eradication
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Summary Global eradication of the guinea worm (Dracunculus medinensis) is near, although perhaps delayed a
little by the discovery of a transmission cycle in dogs. It is therefore an appropriate time to reflect on
the severe impact of this infection on the life of the communities where it was endemic prior to the
start of the global eradication programme in 1981. From 1971 to 1974, we conducted a series of
unpublished studies on guinea worm in a group of villages in Katsina State, northern Nigeria, where
the infection was highly endemic. These studies demonstrated the high rate of infection in affected
communities, the frequent recurrence of the infection in some subjects and the long-standing
disability that remained in some infected individuals. Immunological studies showed a high level of
immediate hypersensitivity to adult worm and larval antigens but a downregulation of Th1-type T-
cell responses to worm antigens. Freeing communities such as those described in this article from the
scourge of guinea worm infection for good will be an important public health triumph.
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Introduction
Thanks to the work of The Carter Foundation, WHO,
other international organisations and local communities,
eradication of the guinea worm Dracunculus medinensis
is imminent [1, 2], although perhaps delayed a little by
the discovery of a transmission cycle in dogs in Chad [3–
5]. The importance of this achievement should not be
underestimated for the devastating impact of this infec-
tion, when uncontrolled, has frequently been neglected.
In this article, we describe our experience of this infection
in northern Nigeria 40 years ago, when it was a truly
neglected disease, to emphasise the public health impor-
tance of its imminent eradication.
In the early 1970s, when the studies described in this
article were carried out, guinea worm was almost com-
pletely unrecognised as a significant health problem in
Nigeria and elsewhere as severely affected subjects were
usually too disabled to travel to the nearest clinic and they
knew that there was little that conventional medicine could
offer them. Thus, at the request of an anthropologist living
in a severely affected community in northern Nigerian, we
initiated a series of studies to describe the clinical features
of guinea worm infections, its impact on the community
and why patients infected with a large worm accessible to
the immune system did not develop a protective immune
response. None of the findings from these studies has been
published due to lack of interest from the scientific and
public health communities at the time that they were car-
ried out. However, as the day approaches when the world
can celebrate the eradication of this infection, we believe
that it is worth recording how guinea worm affected a
group of Nigerian villages prior to the initiation of the
eradication programme in 1981.
Methods
Study area
The study was conducted in a group of villages near to
the town of Malumfashi, northern Nigeria, which were
part of the Malumfashi Endemic Diseases Research Pro-
ject established through a partnership between the Insti-
tute of Health, Ahmadu Bello University (ABU) and the
Liverpool School of Tropical Medicine (Figure 1). The
ecological and demographic characteristics of the area
have been reported previously [6]. Most of the villages in
the study area had a hand-pump well and additional pri-
vate wells within a household were usually in a good
state of repair. However, during the rainy season, small
pools that formed between villages were used for washing
and as a source of drinking water during farming (Fig-
ure 2a). Many of these pools harboured Cyclops, the
intermediate host of the guinea worm.
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Household survey
After preliminary visits to the affected communities, the
village of Dankanjiba was chosen as a typical village for
the conduct of a retrospective survey. The village was
mapped and a census obtained. After consultations with
the village committee, all adult males were invited to par-
ticipate in a survey that enquired about their previous
experience of guinea worm infection and how this had
affected their lives.
Weekly clinics
Following this initial survey, weekly clinics were held in
the study area throughout the rainy season for a period
of 4 years (1971–1974), with visits alternating between
villages each week. If a relative reported a case who was
unable to walk to the clinic, the patient was visited at
home. A history was taken from any subject who pre-
sented with a guinea worm and an examination per-
formed. In 1974, a swab was collected from the site of
an emerging worm for microbiological studies if this
appeared infected in a consecutive series of 42 patients.
Treatment with antibiotics was provided if there were
signs of bacterial infection. Patients were requested to
return for follow-up at the next clinic so that the course
of their illness could be followed but no formal follow-up
procedure was followed. In 1972, a small, open-label
trial of metronidazole was undertaken in 37 patients.
Microbiology
Smears from ulcer sites were made and stained with
Gram stain. Swabs were plated on blood agar plates
within 6 h of collection and cultured aerobically and
3 km
Figure 1 Map of Nigeria showing the site of the study in Katsina State, Nigeria, and a more detailed map of the study area indicating
the area covered by the Malumfashi Endemic Diseases Research Project. Villages circled in red had more than 10 cases.
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anaerobically for 48 h. The predominant colony was
characterised by morphology and by Gram stain and the
species identified using conventional microbiological tech-
niques. Antibiotic sensitivity against penicillin, strepto-
mycin, chloramphenicol, tetracycline and neomycin was
determined using a disc method.
Immunology
The immunological methods employed in the studies are
described only briefly as these are now largely of histori-
cal interest.
Preparation of larval and adult worm antigens. Larvae
were obtained by irrigating the head of a recently
emerged worm with normal saline. The suspension was
then subjected to ultrasound and concentrated by
dialysis against Lyphogel. Segments of adult worm were
obtained from subjects who were being treated locally
by extraction of the worm. Segments of worm were
cleaned, homogenised, heat-inactivated at 56 °C for
10 min and filtered through a Millipore filter and the
protein content of the extract determined. Adult and
larval extracts were fractionated on a Sephadex G150
column.
Skin tests. Test subjects were injected intradermally with
larval or adult antigen preparations at optimum concen-
trations, determined in initial experiments in expatriate
volunteers who had not been exposed to guinea worm,
and the size of the wheal present 10–15 min after injec-
tion was measured in two directions with the average
recorded. Injection sites were examined 48–72 h after
injection.
(a)
(b)
(c)
(e)
(d)
Figure 2 (a) Typical pool used for washing and as a source of drinking water during the farming season, (b) local extraction of a gui-
nea worm using a twig, (c) arthritis of the knee in a patient with a guinea worm emerging above the medial malleolus, (d) synovial nee-
dle biopsy from the patient shown in panel c showing infiltration of the synovium with mononuclear cells, (e) long-standing damage to
the knee and permanent disability following guinea worm arthritis of the knee.
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IgE assays. IgE concentrations were measured using a
commercial radioimmunoassay (Behringwerke).
Precipitin reactions. Sera were tested for precipitating
antibodies using the Ouchterlony technique, by which an
optimum concentration of larval or worm antigen was
placed in the central well of an agar plate and test and
control sera in the surrounding wells. Plates were exam-
ined for precipitin lines 48–72 h later.
Haemagglutination assay. Tanned sheep red blood cells
were coated with larval or adult antigen fractions at opti-
mum concentrations determined in preliminary experi-
ments. Test sera were absorbed overnight with uncoated
red cells to absorb heterophile antibodies, and tested in
doubling dilutions against the coated red cells. The high-
est dilution causing visible haemagglutination was
recorded.
Cell mediated assays. Lymphocytes were obtained from
infected and control subjects after separation on Lympho-
prep and tested for proliferation after stimulation with
larval or adult antigen at optimum concentrations using
H3 thymidine incorporation after 72 h of culture.
Analysis
Data obtained in the field were transcribed onto Excel
spreadsheets and verified. Comparison of categorical vari-
ables was made using a chi-square test, and Student’s t-
test was used to compare means. For some immunologi-
cal variables, variation by sex, age and number of previ-
ous guinea worm infections was determined.
Ethical approval
The study was approved by the Director of Health Ser-
vices, Ahmadu Bello University; the Paramount Chief for
the study area (the Galadima of Malumfashi); and by vil-
lage heads and their advisors. Oral, informed consent
was obtained from study subjects for the collection of
blood samples or for participation in skin testing.
Results
Retrospective survey of guinea worm infection
The population of Dankanjiba was estimated to be
approximately 1200 in 1971 with 250 men over the age
of 16 years; 213 (85%) of the latter participated in the
initial survey. 72% of the interviewees had a clear recol-
lection of infection with a guinea worm at some stage of
their life. Many had had repeated infections with 21%
reporting five or more episodes. The number of episodes
recalled by age group is shown in Table 1. The mean
number increased from 1.93 [95% CI: 1.07; 2.79] in 20-
to 29-year-olds to 3.94 [95% CI: 2.30; 5.58] in the 40-
to 49-year-old group but then fell to a mean of 2.27
[95% CI: 1.34; 4.20] in those aged 60 years or more.
Approximately 10% of the adult male inhabitants had a
guinea worm infection each year. Eleven interviewees
(5.9%) reported that they had been unable to work for
3 months or more because of a guinea worm infection
and three had been disabled for over a year. One subject
reported that his wife had died from an acute illness asso-
ciated with an episode of multiple guinea worm infec-
tions. There was no evidence of clustering in the village
with infections having occurred in nearly all compounds.
Clinical features of guinea worm infection
A total of 563 patients with a patent guinea worm infec-
tion were seen during the rainy seasons of 1971–1974
(Table 2). Cases came from 47 villages scattered across
the study area but they were concentrated in a few larger
villages (Sabon Layi Suran: 208 cases; Dankanjiba: 96
cases; and Mahuta: 62 cases) (Fig. 1). Two-thirds of the
subjects were male. The mean age of affected male sub-
jects (25.8 years [95% CI: 23.9; 27.7]) and female sub-
jects (26.9 years [95% CI: 23.7; 30.1]) was similar
(Figure 3). Cases reported a mean of 1.47 [95% CI: 1.21;
1,75] previous episodes of guinea worm infection; 38
Table 1 Mean numbers of previous guinea worm infections and
resulting disability for 3 months or more in 185* adult male
inhabitants of Dankanjiba village, northern Nigeria, (1971).
Range shown in brackets
Age in
years Number
Mean number
of infections
[95% CI] (range)
Number (%)
with disability
> 3 months
20–29 28 1.93 [1.07; 2.79]
(0–5)
2 (7.1%)
30–39 67 3.06 [2.37; 3.75]
(0–15)
4 (6.0%)
40–49 33 3.94 [2.30; 5.58]
(0–15)
3 (9.1%)
50–59 35 3.49 [2.15; 4.83]
(0–20)
2 (5.7%)
60 or > 22 2.27 [1.34; 4.20]
(0–12)
0
Total 185 3.05 [2.54; 3.56]
(0–20]
11 (5.9%)
*Thirty-two respondents were unsure of whether or not they had
had a previous infection.
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subjects (6.71%) reported having been infected on five or
more occasions. The average duration of symptoms prior
to presentation was 2.61 weeks [95% CI: 2.34; 2.88]
(Table 2). One thousand and twenty worms were seen,
the majority (88.4%) of which were emerging from a leg
(Figure 2b). Approximately one-half of cases had signs of
secondary infection at the site of worm emergence requir-
ing treatment with an antibiotic (Table 2). The average
duration of active infection was 5.94 [95% CI: 5.93;
6.37] weeks but some subjects still had symptoms at that
time and were not followed actively until asymptomatic.
A minority of cases were disabled for a much longer per-
iod of time with at least 98 cases (17.4%) having an
active infection which persisted for 10 weeks or more.
Arthritis. Twenty-six cases of arthritis, defined as a ten-
der, swollen joint with limitation of movement, were
detected during weekly clinics. The mean age of these
patients was 24.72 [95% CI: 19.34; 30.10] years and the
majority (19) were male. Their mean duration of symp-
toms before presentation was 2.63 [95% CI: 1.56; 3.70]
weeks. Most patients had an obvious guinea worm ulcer
near to the affected joint but in two cases the arthritis
appeared before the guinea worm. The knee was the
most frequently affected joint (Figure 2c) but arthritis of
the ankle, wrist and shoulder was also seen (Table 2). An
additional subject was seen with an ankylosed right knee,
fixed at 45%, causing severe difficulty in walking, which
had resulted from a guinea worm infection a year
Table 2 Summary of the findings in 563 Nigerian patients with a patent guinea worm infection
Variable
Year seen
1971 1972 1973 1974 Total
Number of cases 178 113 152 122 563
Sex
Male 135 83 88 73 380
Female 43 30 64 49 183
Age in years (mean [95% CI])
Male 26.4 [23.9, 28.9] 24.5 [21.3, 27.7] 23.8 [20.6, 27.0] 25.1 [21.7, 28.5] 25.8 [23.9, 27.7]
Female 27.1 [22.6, 31.6] 24.5 [18.4, 30.6] 25.5 [22.0, 29.0] 24.8 [21.1, 28.5] 26.9 [23.7, 30.1]
Number of previous infections
Mean [95% CI] 1.9 [1.3, 2.4] 1.3 [1.3, 2.4] 1.1 [0.8, 1.9] 1.5 [0.9, 2.0] 1.5 [1.2, 1.8]
Duration of symptoms (weeks)*
Mean [95% CI] 2.7 [2.3, 3.6] 2.5 [2.1, 2.9] 3.0 [2.2, 3.8] 2.0 [1.7, 2.3] 2.6 [2.3, 2.9]
Duration of illness (weeks)†
Mean [95% CI] 6.5 [5.7, 7.3] 4.2 [3.6, 4.8] 7.2 [6.2, 8.2] 5.0 [4.5, 5.6] 5.9 [5.5, 6.3]
Worms present per person*
1 23 65 92 79 359
2–4 47 35 55 38 175
5 or more 6 13 5 5 29
Site of worm emergence
Leg 283 190 241 188 902
Arm 15 13 17 21 66
Torso 15 11 9 11 46
Other 5 0 1 0 6
Infection at site of emergence
Number (%) 131 (41.5%) 88 (41.1%) 129 (48.1%) 77 (35.0%) 425 (41.7%)
Definite arthritis
Number (%) 13 (7.3%) 5 (4.4%) 6 (3.9%) 2 (1.6%) 26 (4.6%)
Possible arthritis
Number (%) 31 (17.4%) 8 (7.1%) 30 (19.7%) 12 (9.8%) 81 (14.4%)
Site of definite arthritis
Knee 7 2 5 2 16
Ankle 5 1 1 0 7
Wrist 0 2 0 0 2
Shoulder 1 0 0 0 1
*Data missing for 10 subjects.
†Data missing from six subjects.
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previously (Figure 2e). Another nine patients with guinea
worm arthritis were seen at a health centre in the area or
at the local hospital, and synovial aspiration was
performed in these subjects. Two patterns were seen – in
six subjects, viscous fluid was obtained with a relatively
low white blood cell count (300, 600, 800, 2000, 7000
and 17 000, cells per ll), a predominance of lymphocytes
and monocytes and a sterile culture. A synovial needle
biopsy obtained from one of these patients with a large
knee effusion showed infiltration of the synovium with
mononuclear cells (Figure 2d). Purulent synovial fluid
was obtained from the remaining three patients with a
high white blood cell count (27 000, 200 000, 300 000
cells per ll) and a predominance of polymorphonuclear
neutrophil leucocytes. Staphylococcus aureus was
obtained from two of these cases and an a-haemolytic
streptococcus from the third. All the patients made a full
recovery.
Microbiological findings. Swabs were obtained from
ulcers from 42 consecutive subjects over a two-month
period in 1974. S. aureus was the most frequently iso-
lated bacterium (19 isolates) followed by b-haemolytic
streptococci (seven isolates) and a-haemolytic streptococci
(seven isolates). There was one isolate of Escherichia coli
and one of a Klebsiella species. Spore-bearing gram-posi-
tive rods were cultured on three occasions and seen in
direct smears from the ulcer in a further two subjects.
Eleven of the 15 S. aureus isolates tested were penicillin-
resistant.
Treatment. Patients with an active infection were trea-
ted with analgesics and a simple dressing if an ulcer
was present and discouraged from exposing the lesion
to water. Penicillin or chloramphenicol was given if
there was evidence of secondary bacterial infection or
purulent arthritis. Following reports of the potential
benefit of metronidazole [7, 8], 37 patients were allo-
cated randomly to receive aspirin or aspirin plus
metronidazole in a dose of 400 mg/day for 7 days and
followed weekly for 4 weeks using a severity score
(maximum 20). This declined from 7.65 [95% CI:
5.37; 10.23] to 3.57 [95% CI: 1.95; 5.19] in the
aspirin alone group and from 8.00 [95% CI: 6.33;
9.67] to 4.10 [95% CI: 2.61; 5.59] in the aspirin plus
metronidazole group, an almost identical rate of recov-
ery (P > 0.5).
Immunology
IgE concentrations. Serum total IgE levels were mea-
sured in 30 randomly selected adult subjects with an
active guinea worm infection and compared with the val-
ues seen in 20 adult blood donors who attended Ahmadu
Bello University Hospital, Zaria. The mean value
Table 3 Serological findings in patients with active guinea worm
and in healthy adult Nigerian blood donors
Guinea worm
cases Blood donors
Precipitating antibody
Adult worm antigen
Number tested 96 50
Number of precipitin lines (%)
0 74 (77.0%) 48 (96.0%)
1 14 (14.6%) 2 (4.0%)
2 6 (6.3%) 0
3 or > 2 (2.1%) 0
Precipitating antibody
Larval antigen
Number tested 97 20*
Number of precipitin lines (%)
0 75 (77.3%) 19 (95.0%)
1 14 (14.4%) 1 (5.0%)
2 6 (6.2%) 0
3 or > 2 (2.1%) 0
Haemagglutinating antibody
Adult antigen
Number tested 101 50
Number
positive (%)
99 (98.0%) 18 (36.0%)
Mean titre of positives
(log2) [95% CI] 7.88 [7.23; 8.45] 2.17 [1.74; 2.60]
*Only 20 samples were tested because of shortage of antigen.
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Figure 3 Age and sex distribution of 563 Nigerian cases of gui-
nea worm infection.
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obtained in the subjects with an active guinea worm
infection was significantly higher than the mean value
found in healthy blood donors (12 246 IU/ml [95% CI:
10 380; 13 610] and 6607 IU/ml [95% CI: 5720; 7493]
respectively) (P = 0001).
Immediate hypersensitivity skin tests. Preliminary tests
with varying concentrations of adult and larval antigen
preparations in healthy adult, expatriate volunteers
showed that concentrations of approximately 5 lg/ml
protein did not produce any immediate reactivity. Using
this antigen concentration, tests were conducted in 51
randomly selected subjects with an active guinea worm
infection and in 19 control subjects who stated that they
had never had a guinea worm infection. The mean
increase in size of the bleb at the site of intradermal
injection of adult antigen 15 min after injection was
greater in the guinea worm patients than in the controls
(8.10 [95% CI: 6.82; 9.28] mm compared with an
increase of 5.86 [95% CI: 3.87; 7.85] mm in the con-
trols) (P = 0.04). A similar result was found for larval
antigen with increases of 8.54 [95% 7.17; 9.91] mm and
4.54 [95% CI: 2.78; 6.30] mm being recorded in cases
and controls respectively (P < 0.001). No correlation was
found between age or severity of infection and the imme-
diate response. However, for adult worm antigen, 25
subjects with a history of prior infections above the med-
ian number had a smaller reaction than did 24 subjects
with a history of less frequent past infections (mean 1.20
[95% CI: 0.61; 1.79] vs. 2.87 [95% CI: 1.46; 4.28]
[P = 0.03). A similar pattern was seen for larval antigen,
although the difference between groups was not statisti-
cally significant (1.23 [95% CI: 0.43; 2.03] vs. 2.90
[0.81; 4.99] [P = 0.13]).
Precipitin reactions. Precipitin lines were detected signifi-
cantly more frequently in a randomly selected group of
guinea worm infected subjects than in northern Nigerian
blood donors who did not have a history of guinea worm
infection (22/96 [23%] vs. 2/50 [4%]) (P = 0.003)
(Table 3). Similar results were obtained for the larval
antigen, which was detected in 15/97 [15%] infected sub-
jects but in only 1/50 [2%] controls (P < 0.001). No cor-
relation with sex was noted. Subjects who were positive
against adult antigen tended to be younger than those
who were negative (mean age 20.45 [95% CI: 15.33;
25.57] years vs. 27.72 [95% CI: 25.02; 30.42]) years
(P = 0.014) but the opposite trend was seen for larval
antigen with the mean age of positive subjects being
31.80 [95% CI: 23.11; 40.49] years vs. 25.62 [95% CI:
23.22; 28.02] years in those who were negative
(P = 0.07), so this may have been a chance finding. The
number of previous infections reported by positive reac-
tors compared with those who were negative was similar
for both adult antigen (1.54 [95% CI: 0.66; 2.42] vs.
1.78 [95% CI: 1.18; 2.63]) and for larval antigen (1.60
[95% CI: 0.39; 2.83] vs. 1.73 [95% CI: 1.19; 2.50])
(P > 0.5 for each comparison). Six sera showing strong
positive reactions were tested against different fractions
of adult extract obtained on Sephadex G150 fractiona-
tion. Bands were seen most frequently with fractions of
molecular weight in the range of 20 000–100 000.
Haemagglutinating antibodies. Haemagglutinating anti-
bodies to adult antigen at a titre of 1:4 or > were found
in nearly all subjects with guinea worm (99/101) (99%),
compared with a prevalence of 18/50 (36%) in adult
male northern Nigerian blood donors (Table 3). The
mean titre (log2) of the guinea worm patients who were
positive (7.84 [95% CI: 7.23; 8.45] was much higher
than that found in the blood donors (2.17 [95% CI:
1.74; 2.60) (P < 0.001). Those in the age group
≥50 years nearly all had very high titres (mean 8.50
[95% CI: 6.98; 10.02]. A significant association was
noted with the number of previous episodes reported
with mean titres being 6.58 [95% CI: 5.22; 7.94] in those
who reported never having been infected previously, 7.62
[95% CI: 6.89; 8.35] in those with a history of 1–4 pre-
vious infections and 9.54 [95% CI: 7.34; 11.74] in those
with a history of five or more infections (P = 0.03).
Haemagglutinins against red blood cells coated with lar-
val antigen at a titre of 1:4 or greater were found in only
1/25 guinea worm infected subjects and in none of 20
blood donor controls.
Cell mediated immune responses. Skin tests with adult
worm antigen were examined for induration 48 h after
injection in 50 subjects with an active guinea worm infec-
tion. Only three reactions (6%) >5 mm in diameter were
observed. In contrast 75% (21/28) had a positive reaction
of ≥5 mm diameter after intradermal challenge with 10
TU of tuberculin. Lymphocytes from 10 male patients
aged 14–35 years with active guinea worm were cultured
with varying concentrations of adult or larval antigen.
No subject had a rate of proliferation more than twice
that of the control culture at any of the antigen concen-
trations tested.
Discussion
Weekly visits during the rainy seasons of 1971–1974 to a
group of villages typical of many across northern Nigeria
emphasised the debilitating effects of guinea worm on the
community with a significant proportion of the adult
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male population being disabled during the peak farming
season. It is likely that this had an adverse effect on the
nutrition and health of their families during the coming
year, as found in several subsequent studies [9–14]. Gui-
nea worm infection was also an important cause of
absence from school, as noted elsewhere in Nigeria [15].
Guinea worm ulcers readily become secondarily
infected unless carefully managed and this was the case
in this study with many subjects developing a surround-
ing cellulitis. The most frequently isolated bacteria from
infected ulcers were S. aureus and haemolytic strepto-
cocci. Tetanus is a well-recognised complication of gui-
nea worm infection after contamination of the wound
from soil. No cases of tetanus were observed in this
study, although one interviewee reported that his wife
had died from an acute febrile illness associated with
infection by several guinea worms and it is possible that
this was a case of tetanus. Gram-positive, spore-bearing
rods were grown from two subjects although these were
not differentiated further.
Spread of infection to an adjacent joint can lead to a
purulent arthritis, which, if not managed well, can result in
long-term deformity [16, 17]. Purulent arthritis was seen
in three patients in this series. In other patients with arthri-
tis, examination of synovial fluid was sterile and showed a
relatively low white blood cell count characterised by a
predominance of lymphocytes and monocytes, as seen in a
previous study in southern Nigeria [18] suggesting that the
arthritis resulted from an immunological reaction to an
adjacent worm. Reports that treatment with metronidazole
accelerated recovery [7, 8] were not confirmed, as was the
case when this drug was tried in Ghana [19].
The severe reaction that may follow rupture of an adult
worm during extraction has long been recognised and
attributed to an allergic reaction. This supposition is sup-
ported by the observations that nearly all infected subjects
showed an immediate hypersensitivity to adult and larval
antigens, a reaction first described in patients seen in north-
ern Nigeria in 1935 [20], and that infected subjects’ had a
higher overall serum IgE level than blood donors from the
same area. Similar results were found in a subsequent study
carried out in Ilorin, Nigeria, with infected subjects having
a high incidence of positive immediate skin tests and higher
IgE concentrations than controls [21]. However, higher
total IgE levels were not found in a subsequent study in
Ghana [22]. High haemagglutinin antibody titres to worm
antigen were found in nearly all infected subjects and were
highest in those with a history of several prior infections;
precipitating antibodies were detected less frequently.
Bloch et al. [23] have subsequently investigated the anti-
body response to guinea worm infection in more detail.
Antibodies of the IgG4 subclass gave the best
discrimination between cases and controls resident in an
area that was not endemic for guinea worm.
Little evidence was found that infected subjects devel-
oped any protective immunity. The infection rate was
lower in older than middle-aged men but this may have
been due to less exposure of the older men. Many sub-
jects had recurrent infections each year for many years. It
seems likely that the guinea worm has the ability to
downregulate aspects of the immune response that might
contribute to protection and a clue as to what this might
be was found by the inability to detect any evidence of a
cellular immune response to adult antigen by delayed
hypersensitivity skin testing or by lymphocyte prolifera-
tive studies. Aiyedun et al. [21] also noted an absence of
a delayed skin test response in guinea worm patients, and
Knoop et al. [24] subsequently showed a diminished ThI-
type 1 cytokine response in subjects with an active infec-
tion together with enhanced IL-10 production on stimula-
tion with guinea worm and cross-reactive antigens in
keeping with these earlier findings.
The results presented in this study have a number of
weaknesses. The patient population was relatively unse-
lected and some very severe cases may have been missed
despite home visits being made when requested. Selection
of subjects for individual substudies was not performed
as rigorously as would now be required and for the
immunological studies the control group was locally
recruited blood donors rather than age, sex and commu-
nity-matched controls as would have been preferable.
Nevertheless, it is likely that the main conclusions from
the immunological studies are valid.
As the world prepares to celebrate the eradication of
the guinea worm, it is important to remember the mas-
sive health and social burden caused by this worm in
communities such as the ones described in this article and
the magnitude of the achievement in ridding the world of
this debilitating infection.
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